New optical method promises faster, more accurate diagnosis of breast cancer
Researchers report on data-based method to replace manual inspection of tissue
A new optical method for more quickly and accurately determining whether breast tissue lesions are cancerous is described by University of Illinois researchers.
Figure 3 from a new article in the Journal of Biomedical Optics compares stained bright-field microscopy (top row) and SLIM (bottom row) images in their respective abilities to show malignant and benign. The images were obtained from adjacent sections. Color bars are in radians.
Hassaan Majeed, Univ. of Illinois, et al./SPIE
University of Illinois at Urbana-Champaign and Chicago researchers Hassaan Majeed, Mikhail Kandel, Kevin Han, Zelun Luo, Virgilia Macias, Krishnarao Tangella, Andre Balla, and Gabriel Popescu report on a quantitative method for diagnosing breast cancer using spatial light interference microscopy (SLIM).
Because this method is based on quantitative data rather than a subjective assessment, the researchers expect that these preliminary results show the potential of their technique to become the basis for an automated image analysis system that would provide a fast and accurate diagnostic method.
When an abnormality in the breast is discovered, standard practice is for the physician to take a tissue biopsy, which is then stained to provide enough contrast for a pathologist to study key features of the tissue under a microscope. The tissue analysis is done manually. Due to variations such as staining intensity and the illumination used, the process does not lend itself to automation.
Manual inspections, however, are subject to investigator bias, and the process is time-consuming. This can, in some cases, result in late diagnosis - a critical shortcoming given that early diagnosis significantly improves chances of survival.
Using the breast tissue biopsies of 400 different patients, researchers selected two parallel, adjacent sections from each biopsy. One was stained and the other left unstained.
The unstained samples were analyzed using a SLIM module attached to a commercial phase contrast microscope to generate interferograms.
Four interferograms were used to produce one quantitative image showing areas with different refractive properties in different colors. The boundary between tumors and the cells around them were clearly delineated, making it possible to assess whether the tumors were malignant or benign.
Original publication
Other news from the department science
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Most read news
More news from our other portals
See the theme worlds for related content
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.
